TrialThe journal of allergy and clinical immunology. In practice2023

Double-Blind, Placebo-Controlled Study of E-B-FAHF-2 in Combination With Omalizumab-Facilitated Multiallergen Oral Immunotherapy.

Julie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.